Skip to main content
SpringerLink
Log in

Pharmacological management of stable angina pectoris aims to relieve symptoms and maximize survival

  • Disease Management
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

Abstract

Stable angina pectoris is thought to result from a mismatch between myocardial oxygen demand and supply. The optimal management of this condition involves relieving symptoms and maximizing survival. Pharmacological options for angina relief include organic nitrates, β-blockers, calcium channel blockers and ranolazine, with the choice of agent based on several factors, including the patient’s circulatory status. Lifestyle changes and/or concomitant therapy with acetylsalicylic acid and/or a statin are employed to improve survival.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Rousan TA, Mathew ST, Thadani U. Drug therapy for stable angina pectoris. Drugs. 2017;77(3):265–84.

    Article  CAS  PubMed  Google Scholar 

  2. Montalescot G, Sechtem U, Achenbach S, et al. 2013 ESC guidelines on the management of stable coronary artery disease: the task force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J. 2013;34(38):2949–3003.

    Article  PubMed  Google Scholar 

  3. Fihn SD, Gardin JM, Abrams J, et al. 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2012;60(24):e44–164.

    Article  PubMed  Google Scholar 

  4. Thadani U. Management of stable angina—current guidelines: a critical appraisal. Cardiovasc Drugs Ther. 2016;30(4):419–26.

    Article  PubMed  Google Scholar 

  5. Huang HL, Fox KA. The impact of beta-blockers on mortality in stable angina: a meta-analysis. Scott Med J. 2012;57(2):69–75.

    Article  CAS  PubMed  Google Scholar 

  6. Bangalore S, Steg G, Deedwania P, et al. β-Blocker use and clinical outcomes in stable outpatients with and without coronary artery disease. JAMA. 2012;308(13):1340–9.

    Article  CAS  PubMed  Google Scholar 

  7. Thadani U. Challenges with nitrate therapy and nitrate tolerance: prevalence, prevention, and clinical relevance. Am J Cardiovasc Drugs. 2014;14(4):287–301.

    Article  CAS  PubMed  Google Scholar 

  8. Camm AJ, Maltz MB. A controlled single-dose study of the efficacy, dose response and duration of action of nicorandil in angina pectoris. Am J Cardiol. 1989;63(21):61J–5J.

    Article  CAS  PubMed  Google Scholar 

  9. IONA Study Group. Effect of nicorandil on coronary events in patients with stable angina: the Impact Of Nicorandil in Angina (IONA) randomised trial. Lancet. 2002;359(9314):1269–75.

    Article  Google Scholar 

  10. Thadani U. Can nicorandil treat angina pectoris effectively? Nat Clin Pract Cardiovasc Med. 2005;2(4):186–7.

    Article  CAS  PubMed  Google Scholar 

  11. Chaitman BR, Skettino SL, Parker JO, et al. Anti-ischemic effects and long-term survival during ranolazine monotherapy in patients with chronic severe angina. J Am Coll Cardiol. 2004;43(8):1375–82.

    Article  CAS  PubMed  Google Scholar 

  12. Chaitman BR, Pepine CJ, Parker JO, et al. Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial. JAMA. 2004;291(3):309–16.

    Article  CAS  PubMed  Google Scholar 

  13. Kosiborod M, Arnold SV, Spertus JA, et al. Evaluation of ranolazine in patients with type 2 diabetes mellitus and chronic stable angina: results from the TERISA randomized clinical trial (Type 2 diabetes evaluation of ranolazine in subjects with chronic stable Angina). J Am Coll Cardiol. 2013;61(20):2038–45.

    Article  CAS  PubMed  Google Scholar 

  14. Peng S, Zhao M, Wan J, et al. The efficacy of trimetazidine on stable angina pectoris: a meta-analysis of randomized clinical trials. Int J Cardiol. 2014;177(3):780–5.

    Article  PubMed  Google Scholar 

  15. Lloyd-Jones DM, Morris PB, Ballantyne CM, et al. 2016 ACC expert consensus decision pathway on the role of non-statin therapies for LDL-cholesterol lowering in the management of atherosclerotic cardiovascular disease risk: a report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol. 2016;68(1):92–125.

    Article  PubMed  Google Scholar 

  16. Codolosa JN, Acharjee S, Figueredo VM. Update on ranolazine in the management of angina. Vasc Health Risk Manag. 2014;10:353–62.

    CAS  PubMed  PubMed Central  Google Scholar 

  17. Morrow DA, Scirica BM, Karwatowska-Prokopczuk E, et al. Effects of ranolazine on recurrent cardiovascular events in patients with non-ST-elevation acute coronary syndromes: the MERLIN-TIMI 36 randomized trial. JAMA. 2007;297(16):1775–83.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

    Consortia

    Adis Medical Writers

    Ethics declarations

    The article was adapted from Drugs [1] by employees of Adis/Springer and was not supported by any external funding.

    Rights and permissions

    Reprints and permissions

    About this article

    Check for updates. Verify currency and authenticity via CrossMark

    Cite this article

    Adis Medical Writers. Pharmacological management of stable angina pectoris aims to relieve symptoms and maximize survival. Drugs Ther Perspect 33, 375–381 (2017). https://doi.org/10.1007/s40267-017-0420-z

    Download citation

    • Published:

    • Issue Date:

    • DOI: https://doi.org/10.1007/s40267-017-0420-z

    Search

    Navigation